VICTORIA MERAZ: Open Payments
NPI 1003270752 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,798 in 86 payments from 22 companies in 2025. Trend: 2023 $1,225 · 2024 $850 · 2025 $1,798
Food & beverage: $1,726Education: $72
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $294 |
| Incyte Corporation | 17 | $256 |
| Lilly USA, LLC | 7 | $214 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $177 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $128 |
| UCB, Inc. | 6 | $121 |
| Regeneron Healthcare Solutions, Inc. | 3 | $77 |
| Janssen Biotech, Inc. | 1 | $72 |
| Arcutis Biotherapeutics, Inc. | 3 | $56 |
| ABBVIE INC. | 2 | $55 |
Products named: OPZELURA, COSENTYX, ILUMYA, JOURNAVX, TALTZ, Bimzelx, DUPIXENT, EBGLYSS.
Industry payments across TX — which companies pay providers there.
